Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience

Risk-reducing surgery (RRS) is recommended in BRCA-mutated carriers because of their increased risk of developing ovarian cancer, while its role is still discussed for women harboring mutations in non-BRCA homologous repair genes. The aim of this study was to retrospectively evaluate the occurrence...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassani, Chiara, Rossi, Chiara, Camnasio, Cristina Angela, Urtis, Mario, Fiandrino, Giacomo, Grasso, Maurizia, Zanellini, Francesca, Lucioni, Marco, D’Ambrosio, Gioacchino, Di Toro, Alessandro, Rossi, Margherita, Roccio, Marianna, Ferrari, Alberta, Secondino, Simona, Nappi, Rossella Elena, Arbustini, Eloisa, Paulli, Marco, Spinillo, Arsenio, Cesari, Stefania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776991/
https://www.ncbi.nlm.nih.gov/pubmed/36553061
http://dx.doi.org/10.3390/diagnostics12123054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776991/
https://www.ncbi.nlm.nih.gov/pubmed/36553061
http://dx.doi.org/10.3390/diagnostics12123054

Ejemplares similares